Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-13

FDA Approved: PROVAYBLUE — Supplemental Application (American Regent, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ProvayBlue (methylene blue) from American Regent, Inc., likely to update or expand the labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROVAYBLUE (METHYLENE BLUE)

Snippet

SUPPL AP for PROVAYBLUE (METHYLENE BLUE)